Medicine
Lisdexamfetamine 40 mg capsule
Lisdexamfetamine 40 mg capsule is a generic prescription medicine for oral use, made by 18 labelers, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Store at room temperature, 20° to 25°C (68° to 77°F), excursions permitted…
Key facts
- Active ingredient (INN)
- Lisdexamfetamine
- Brand
- Sold under the generic name
- Strength
- 40 mg
- Dosage form
- Capsule
- Route
- Oral
- Packs
- 100 capsules, 90 capsules, 30 blister pack and 16 more
- Manufacturers
- Camber PharmaceuticalsIndiaGranules IndiaIndiaSun Pharmaceutical IndustriesIndiaBryant Ranch PrepackAlvogenAmerican Health PackagingAmneal PharmaceuticalsApotexAvKAREElite Laboratories
- Origin register
- US FDA, United States
- Storage
- Store at room temperature, 20° to 25°C (68° to 77°F), excursions permitted between 15° and 30°C (59° to 86 ° F).
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Schedule CII
- ATC code
- N06BA12 Lisdexamfetamine
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 25 August 2023
- Identifiers
- RxCUI 854830, 854834, 854838 +7DailyMed set ID 36c40404-fe94-6fb7-e063-6394a90a2657, d918b40d-a461-41bc-b6c0-83dc76c28e32, 0e024b69-567c-4b40-9c3e-a2daec34256c +15NDC 42291-038, 42858-164, 64850-553 +15Application ANDA202830, ANDA215330, ANDA218604 +12
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
Packs from every labeler of this generic presentation.
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 100 capsule in 1 bottle | 31722-353-01 | Camber PharmaceuticalsIndia | 9 September 2024 |
| 100 capsule in 1 bottle | 70010-209-01 | Granules IndiaIndia | 29 January 2025 |
| 100 capsule in 1 bottle | 57664-049-88 | Sun Pharmaceutical IndustriesIndia | 25 August 2023 |
| 100 capsule in 1 bottle | 47781-565-01 | Alvogen | 25 August 2023 |
| 90 capsule in 1 bottle | 65162-025-09 | Amneal Pharmaceuticals | 28 August 2023 |
| 100 capsule in 1 bottle | 60505-4742-1 | Apotex | 9 November 2023 |
| 100 capsule in 1 bottle | 64850-553-01 | Elite Laboratories | 15 November 2024 |
| 100 capsule in 1 bottle | 0054-0372-25 | Hikma Pharmaceuticals | 25 August 2023 |
| 100 capsule in 1 bottle | 0527-4664-37 | Lannett | 25 August 2023 |
| 90 capsule in 1 bottle, plastic | 0378-6857-77 | Mylan Pharmaceuticals | 25 August 2023 |
| 100 capsule in 1 bottle, plastic | 42858-164-01 | Rhodes Pharmaceuticals | 30 January 2024 |
| 100 capsule in 1 bottle | 0781-2478-01 | Sandoz | 16 September 2025 |
| 100 capsule in 1 bottle | 43547-605-10 | Solco Healthcare US,LLC | 26 August 2023 |
| 100 capsule in 1 bottle | 0406-5114-01 | SpecGx | 25 August 2023 |
| 100 capsule in 1 bottle | 0480-3568-01 | Teva Pharmaceuticals | 17 December 2024 |
| 30 blister pack in 1 carton / 1 capsule in 1 blister pack | 60687-918-21 | American Health Packaging | 24 December 2025 |
| 90 capsule in 1 bottle | 42291-038-90 | AvKARE | 4 June 2025 |
| 100 capsule in 1 bottle | 72162-2455-1 | Bryant Ranch Prepack | 16 March 2026 |
| 90 capsule in 1 bottle | 72162-2455-9 | Bryant Ranch Prepack | 16 March 2026 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
| Register | Status | Source |
|---|---|---|
| US FDA | Listed, marketed | Source record for this pageChecked 12 November 2026 |
| US FDA | First approved 23 February 2007 | Drugs@FDA |
| EU (EMA) | Not recorded | — |
| India (CDSCO) | Not yet confirmed against CDSCO approval lists | — |
| United States | Registered | US FDA (NDC directory, openFDA)Checked 12 November 2026 |
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Alternatives
Other makers and brands of Lisdexamfetamine 40 mg capsule.
Other strengths and forms of Lisdexamfetamine
Clinical summary
Lisdexamfetamine is a central nervous system stimulant indicated for the treatment of attention Deficit Hyperactivity Disorder (ADHD) in adults and pediatric patients 6 years and older, among other approved uses. MedsAcross supplies Lisdexamfetamine for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about LisdexamfetamineFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- Vyvanse prescribing information (Takeda Pharmaceuticals) · U.S. National Library of Medicine, DailyMed
Need Lisdexamfetamine 40 mg capsule for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.